An investigation into a small drug trial that went disastrously wrong in the UK has found that the drug maker and the clinical trial organization that mounted the study had not made any mistakes in formulating the drug or administering it. Instead, the regulators said, TGN1412 had provoked an unexpected biologic reaction in humans, sending six men to the hospital.
- here's the article from the Guardian